TCNNF - Trulieve Cannabis Corp.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.03
|
Rev Est: $297.4M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$47.21
DETAILS
HIGH:
$65.00
LOW:
$18.00
MEDIAN:
$52.92
CONSENSUS:
$47.21
UPSIDE:
638.81%
Market Cap:
1.22B
Volume:
127,500
Avg Volume:
545,760
52 Week Range:
3.02-11.83
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
1.69
Last Dividend:
$N/A
Exchange:
OTC
Country:
US
Employees:
6,000
IPO Date:
2018-09-27
EPS (TTM):
-0.82
P/E Ratio:
-6.37
Revenue (TTM):
1.19B
Total Assets:
2.87B
Total Debt:
824.46M
Cash & Equiv:
238.80M
Rev Growth (5Y):
36.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
3.4%
Debt/Equity:
0.65
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-08-06 | $-0.07 | $-0.07 | -7.6% | $302.1M | $287.1M | +5.2% |
| 2025-05-07 | $-0.17 | $-0.08 | -112.5% | $297.8M | $304.1M | -2.1% |
| 2025-02-26 | $-0.27 | $-0.18 | -50.0% | $301.1M | $292.4M | +3.0% |
| 2024-11-05 | $-0.33 | $-0.13 | -153.8% | $284.3M | $292.5M | -2.8% |
| 2024-08-06 | $-0.06 | $-0.08 | +25.0% | $303.4M | $293.8M | +3.3% |
| 2024-05-09 | $-0.12 | $-0.10 | -20.0% | $297.6M | $286.1M | +4.0% |
| 2024-02-29 | $-0.18 | $-0.16 | -12.5% | $287.0M | $267.9M | +7.1% |
| 2023-11-09 | $-0.14 | $-0.17 | +17.6% | $275.2M | $268.8M | +2.4% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19B | 1.13B | 1.24B | 938.38M | 521.53M | 252.82M | 102.82M | 19.78M | 161,145 |
| Net Income | (155.10M) | (526.80M) | (205.10M) | 18.03M | 63.00M | 178.03M | 42.97M | (36,352) | (7,325) |
| EPS | -0.82 | -2.84 | -1.10 | 0.13 | 0.55 | 1.62 | 0.42 | -0.00 | -0.00 |
| Total Assets | 2.87B | 2.73B | 3.40B | 3.41B | 816.11M | 590.89M | 162.07M | 89,369 | 103,702 |
| Total Debt | 824.46M | 792.57M | 1.03B | 859.02M | 168.60M | 204.24M | 21.03M | 14.46M | 5.44M |
| Cash & Equivalents | 238.80M | 201.37M | 212.30M | 230.65M | 146.71M | 91.81M | 24.43M | 20,916 | 38,848 |
| Operating Cash Flow | 271.48M | 201.84M | 23.10M | 12.90M | 99.64M | 23.51M | 24.96M | (20,606) | (59,726) |
| Free Cash Flow | 149.96M | 146.35M | (161.49M) | (293.22M) | (47.10M) | (51.19M) | (20.47M) | (5.53M) | (3.52M) |
| FCF per Share | 0.79 | 0.77 | -0.86 | -2.06 | -0.41 | -0.46 | -0.20 | -0.05 | -0.03 |
| Book Value | 1.26B | 1.41B | 1.93B | 2.15B | 447.90M | 282.36M | 104.22M | (279,624) | (227,598) |
| Cash & ST Investments | 299.20M | 201.37M | 212.30M | 230.65M | 146.71M | 91.81M | 24.43M | 86,324 | 100,599 |
| ROC Equity | -0.12 | -0.37 | -0.11 | 0.01 | 0.14 | 0.63 | 0.41 | N/A | N/A |